Enerpac Tool
EPAC
Precision Drilling
PDS
Workday
WDAY
4
Halozyme Therapeutics
HALO
5
Cars.com
CARS
US Stock MarketDetailed Quotes
CADL Candel Therapeutics
- 8.215
- -0.445-5.14%
Trading Mar 25 14:16 ET
388.04MMarket Cap-4.72P/E (TTM)
8.610High8.025Low338.43KVolume8.510Open8.660Pre Close2.78MTurnover0.94%Turnover RatioLossP/E (Static)47.24MShares14.60052wk High5.85P/B295.13MFloat Cap1.56052wk Low--Dividend TTM35.93MShs Float14.780Historical High--Div YieldTTM6.75%Amplitude0.660Historical Low8.202Avg Price1Lot Size
Candel Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -13.08%33.37M | -21.37%8.14M | -1.04%8.76M | -10.41%8.57M | -17.87%7.9M | 10.32%38.39M | 28.08%10.35M | -0.71%8.85M | 8.91%9.57M | 6.70%9.62M |
| Selling and administrative expenses | 1.24%14.06M | 8.63%3.32M | 10.78%3.34M | -1.45%3.59M | -8.74%3.8M | -1.24%13.89M | -3.16%3.06M | -14.71%3.02M | -3.11%3.65M | 15.67%4.16M |
| -General and administrative expense | 1.24%14.06M | 8.63%3.32M | 10.78%3.34M | -1.45%3.59M | -8.74%3.8M | -1.24%13.89M | -3.16%3.06M | -14.71%3.02M | -3.11%3.65M | 15.67%4.16M |
| Research and development costs | -21.19%19.31M | -33.63%4.82M | -7.34%5.42M | -16.09%4.98M | -25.00%4.1M | 17.89%24.51M | 45.98%7.26M | 8.72%5.85M | 18.16%5.93M | 0.96%5.47M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12K | ---12K | ---12K |
| Operating profit | 13.08%-33.37M | 21.37%-8.14M | 1.04%-8.76M | 10.41%-8.57M | 17.87%-7.9M | -10.72%-38.39M | -28.57%-10.35M | 0.36%-8.85M | -9.30%-9.57M | -7.07%-9.62M |
| Net non-operating interest income expense | -95.33%-1M | 61.24%-100K | -50.30%-251K | -71.20%-327K | -419.61%-326K | -4.90%-514K | -214.16%-258K | 5.11%-167K | 47.67%-191K | 158.29%102K |
| Non-operating interest income | -47.81%1.09M | -30.12%290K | -52.99%236K | -47.02%240K | -54.99%320K | 70.85%2.08M | -48.38%415K | 46.36%502K | 547.14%453K | --711K |
| Non-operating interest expense | -19.46%2.09M | -42.05%390K | -27.20%487K | -11.96%567K | 6.08%646K | 51.93%2.6M | 16.44%673K | 28.90%669K | 48.05%644K | --609K |
| Other net income (expense) | -2,253.42%-20.8M | -1,107.45%-5.83M | -381.93%-1.64M | -9,363.19%-13.34M | -99.03%7K | -94.10%966K | -117.60%-483K | 57.45%581K | -97.10%144K | -91.26%724K |
| Gain on sale of security | -2,253.42%-20.8M | -1,107.45%-5.83M | -381.93%-1.64M | -9,363.19%-13.34M | -99.03%7K | -94.10%966K | -117.60%-483K | 57.45%581K | -97.10%144K | -91.26%724K |
| Income before tax | -45.44%-55.18M | -26.84%-14.07M | -26.21%-10.65M | -131.30%-22.24M | 6.53%-8.22M | -101.87%-37.94M | -118.28%-11.1M | 2.91%-8.44M | -131.72%-9.61M | -906.29%-8.8M |
| Income tax | ||||||||||
| Net income | -45.44%-55.18M | -26.84%-14.07M | -26.21%-10.65M | -131.30%-22.24M | 6.53%-8.22M | -101.87%-37.94M | -118.28%-11.1M | 2.91%-8.44M | -131.72%-9.61M | -906.29%-8.8M |
| Net income continuous Operations | -45.44%-55.18M | -26.84%-14.07M | -26.21%-10.65M | -131.30%-22.24M | 6.53%-8.22M | -101.87%-37.94M | -118.28%-11.1M | 2.91%-8.44M | -131.72%-9.61M | -906.29%-8.8M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -45.44%-55.18M | -26.84%-14.07M | -26.21%-10.65M | -131.30%-22.24M | 6.53%-8.22M | -101.87%-37.94M | -118.28%-11.1M | 2.91%-8.44M | -131.72%-9.61M | -906.29%-8.8M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -45.44%-55.18M | -26.84%-14.07M | -26.21%-10.65M | -131.30%-22.24M | 6.53%-8.22M | -101.87%-37.94M | -118.28%-11.1M | 2.91%-8.44M | -131.72%-9.61M | -906.29%-8.8M |
| Basic earnings per share | -32.82%-1.74 | -5.26%-0.4 | -13.79%-0.33 | -124.24%-0.74 | 6.67%-0.28 | -101.54%-1.31 | -111.11%-0.38 | 3.33%-0.29 | -135.71%-0.33 | -900.00%-0.3 |
| Diluted earnings per share | -32.82%-1.74 | -5.26%-0.4 | -13.79%-0.33 | -124.24%-0.74 | 6.67%-0.28 | -101.54%-1.31 | -111.11%-0.38 | 3.33%-0.29 | -135.71%-0.33 | -900.00%-0.3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call